Biotech · Private company · Cary, NC, US
Artiam Bio Inc.
Track this companyFree. Adds Artiam Bio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Validation of APT101 for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in an Aging Murine ModelFiscal year 2026 · $279.5KNIH RePORTER 5R41AG090138-02 · fetched Nov 12, 2026
- Validation of APT101 for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in an Aging Murine ModelFiscal year 2025 · $292.3KNIH RePORTER 1R41AG090138-01A1 · fetched Nov 12, 2026